Skip to content

How Would the Creation of a Follow-up Methodology in Consultation Improve the Care of the Epileptic Patient?

How Would the Creation of a Follow-up Methodology in Consultation Improve the Care of the Epileptic Patient?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05741541
Acronym
MAPE
Enrollment
15
Registered
2023-02-23
Start date
2023-02-24
Completion date
2023-04-29
Last updated
2023-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

The goal of this observationnal study is to identify the informative and educational needs of epilepsy patients to avoid interrupting the therapeutic pathway. The main question it aims to answer are : * Identify the patient's expectations of a nurse specializing in epilepsy in the areas of information, predictive elements of good care and adaptation to their state of health * Identify under-addressed or misunderstood themes * Identify patient resources and interventions already in place * Ensuring better continuity of care * Improve the knowledge of patients and their relatives about the management of their pathology After a consultation with the neurologist (as part of their usual follow-up), the participants will be referred to a nurse for a semi-directive, individual interview, lasting 30 minutes and composed of open and closed questions. The announcement of the diagnosis, the quality of life or the factors contributing to the difficulties and their repercussions on a daily basis will be discussed during the interview.

Interventions

None listed

Sponsors

Hopital Nord Franche-Comte
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Adult epileptic patients, over 18 years old * Patients with focal or generalized epilepsy * Patients affiliated or entitled to a social security scheme * Patients who have received informed information about the study and who have co- signed, with the investigator, a non-objection to participation in the study * Patients whose diagnosis has been made for at least 6 months

Exclusion criteria

* Patients with intellectual disabilities * Minors * Untreated patients, in remission * Patients without affiliation to a social security scheme * Patients under guardianship or curatorship

Design outcomes

Primary

MeasureTime frame
Identify the informative and educational needs of epileptic patients to avoid disrupting the therapeutic course by an interview with an nurse.At inclusion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026